Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1963 Aug;42(8):1330–1339. doi: 10.1172/JCI104817

MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS*

T F Yü 1, P G Dayton 1, A B Gutman 1
PMCID: PMC289403  PMID: 14060403

Full text

PDF
1330

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H. A drug-induced change in the distribution and renal excretion of sulfonamides. J Pharmacol Exp Ther. 1961 Dec;134:291–303. [PubMed] [Google Scholar]
  2. BURNS J. J., ROSE R. K., CHENKIN T., GOLDMAN A., SCHULERT A., BRODIE B. B. The physiological disposition of phenylbutazone (butazolidin) in man and a method for its estimation in biological material. J Pharmacol Exp Ther. 1953 Nov;109(3):346–357. [PubMed] [Google Scholar]
  3. BURNS J. J., YU T. F., BERGER L., GUTMAN A. B. Zoxazolamine: physiological disposition, uricosuric properties. Am J Med. 1958 Sep;25(3):401–408. doi: 10.1016/0002-9343(58)90079-2. [DOI] [PubMed] [Google Scholar]
  4. BURNS J. J., YU T. F., DAYTON P., BERGER L., GUTMAN A. B., BRODIE B. B. Relationship between pKa and uricosuric activity in phenylbutazone analogues. Nature. 1958 Oct 25;182(4643):1162–1163. doi: 10.1038/1821162a0. [DOI] [PubMed] [Google Scholar]
  5. BURNS J. J., YU T. F., RITTERBAND A., PEREL J. M., GUTMAN A. B., BRODIE B. B. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. J Pharmacol Exp Ther. 1957 Mar;119(3):418–426. [PubMed] [Google Scholar]
  6. DAVISON C., SMITH P. K. The binding of salicylic acid and related substances to purified proteins. J Pharmacol Exp Ther. 1961 Aug;133:161–170. [PubMed] [Google Scholar]
  7. DAYTON P. G., SICAM L. E., LANDRAU M., BURNS J. J. Metabolism of sulfinpyrazone (Anturane) and other thio analogues of phenylbutazone in man. J Pharmacol Exp Ther. 1961 Jun;132:287–290. [PubMed] [Google Scholar]
  8. GIEBISCH G. Kidney, water and electrolyte metabolism. Annu Rev Physiol. 1962;24:357–420. doi: 10.1146/annurev.ph.24.030162.002041. [DOI] [PubMed] [Google Scholar]
  9. GUTMAN A. B., DAYTON P. G., YU T. F., BERGER L., CHEN W., SICAM L. E., BURNS J. J. A study of the inverse relationship between pKa and rate of renal excretion of phenylbutazone analogs in man and dog. Am J Med. 1960 Dec;29:1017–1033. doi: 10.1016/0002-9343(60)90082-6. [DOI] [PubMed] [Google Scholar]
  10. GUTMAN A. B., YU T. F. A three-component system for regulation of renal excretion of uric acid in man. Trans Assoc Am Physicians. 1961;74:353–365. [PubMed] [Google Scholar]
  11. GUTMAN A. B., YU T. F., BERGER L. Tubular secretion of urate in man. J Clin Invest. 1959 Oct;38:1778–1781. doi: 10.1172/JCI103956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. GUTMAN A. B., YU T. F. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians. 1951;64:279–288. [PubMed] [Google Scholar]
  13. GUTMAN A., YU T. F., SIROTA J. H. A study, by simultaneous clearance techniques, of salicylate excretion in man: effect of alkalinization of the urine by bicarbonate administration; effect of probenecid. J Clin Invest. 1955 May;34(5):711–721. doi: 10.1172/JCI103124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. KERSLEY G. D., COOK E. R., TOVEY D. C. Value of uricosuric agents and in particular of G. 28 315 in gout. Ann Rheum Dis. 1958 Sep;17(3):326–333. doi: 10.1136/ard.17.3.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. LATHEM W., DAVIS B. B., RODNAN G. P. Renal tubular secretion of uric acid in the mongrel dog. Am J Physiol. 1960 Jul;199:9–12. doi: 10.1152/ajplegacy.1960.199.1.9. [DOI] [PubMed] [Google Scholar]
  16. OGRYZLO M. A., HARRISON J. Evaluation of uricosuric agents in chronic gout. Ann Rheum Dis. 1957 Dec;16(4):425–437. doi: 10.1136/ard.16.4.425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. PASCALE L. R., DUBIN A., HOFFMAN W. S. Therapeutic value of probenecid (benemid) in gout. J Am Med Assoc. 1952 Jul 26;149(13):1188–1194. doi: 10.1001/jama.1952.02930300014004. [DOI] [PubMed] [Google Scholar]
  18. REED E. B., FEICHTMEIR T. V., CRAIG S. G. Zoxazolamine as a uricosuric agent. I. Acute effects in healthy non-ghouty subjects. Arthritis Rheum. 1961 Oct;4:533–551. doi: 10.1002/art.1780040509. [DOI] [PubMed] [Google Scholar]
  19. REYNOLDS R. C., CLUFF L. E. Interaction of serum and sodium salicylate: changes during acute infection and its influence on pharmacological activity. Bull Johns Hopkins Hosp. 1960 Nov;107:278–290. [PubMed] [Google Scholar]
  20. SCHACHTER D., MANIS J. G. Salicylate and salicyl conjugates: fluorimetric estimation, biosynthesis and renal excretion in man. J Clin Invest. 1958 Jun;37(6):800–807. doi: 10.1172/JCI103667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SCHREINER G. E. Determination of inulin by means of resorcinol. Proc Soc Exp Biol Med. 1950 May;74(1):117–120. doi: 10.3181/00379727-74-17827. [DOI] [PubMed] [Google Scholar]
  22. SEEGMILLER J. E., GRAYZEL A. I. Use of the newer uricosuric agents in the management of gout. JAMA. 1960 Jul 9;173:1076–1080. doi: 10.1001/jama.1960.03020280016004. [DOI] [PubMed] [Google Scholar]
  23. SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. STAFFORD W. L. The binding by bovine plasma and plasma fractions of salicylic acid and some of its 3-alkyl analogues. Biochem Pharmacol. 1962 Aug;11:685–692. doi: 10.1016/0006-2952(62)90035-7. [DOI] [PubMed] [Google Scholar]
  25. STERLING K., ROSEN P., TABACHNICK M. Equilibrium dialysis studies of the binding of thyroxine by human serum albumin. J Clin Invest. 1962 May;41:1021–1030. doi: 10.1172/JCI104552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. WEINER I. M., GARLID K. D., ROMEO J. A., MUDGE G. H. Effects of tubular secretion and reabsorption on titration curves of tubular transport. Am J Physiol. 1961 Feb;200:393–399. doi: 10.1152/ajplegacy.1961.200.2.393. [DOI] [PubMed] [Google Scholar]
  27. WEINER I. M., WASHINGTON J. A., 2nd, MUDGE G. H. Studies on the renal excretion of salicylate in the dog. Bull Johns Hopkins Hosp. 1959 Nov;105:284–297. [PubMed] [Google Scholar]
  28. WOOD P. H. Salicylates. Bull Rheum Dis. 1963 Jan;13:297–300. [PubMed] [Google Scholar]
  29. YU T. F., BERGER L., KUPFER S., GUTMAN A. B. Tubular secretion of urate in the dog. Am J Physiol. 1960 Dec;199:1199–1204. doi: 10.1152/ajplegacy.1960.199.6.1199. [DOI] [PubMed] [Google Scholar]
  30. YU T. F., BURNS J. J., GUTMAN A. B. Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects. Arthritis Rheum. 1958 Dec;1(6):532–543. doi: 10.1002/art.1780010606. [DOI] [PubMed] [Google Scholar]
  31. YU T. F., GUTMAN A. B. Paradoxical retention of uric acid by uricosuric drugs in low dosage. Proc Soc Exp Biol Med. 1955 Nov;90(2):542–547. doi: 10.3181/00379727-90-22094. [DOI] [PubMed] [Google Scholar]
  32. YU T. F., GUTMAN A. B. Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man. J Clin Invest. 1959 Aug;38(8):1298–1315. doi: 10.1172/JCI103905. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES